Cargando…

Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma

BACKGROUND: Neoadjuvant anti-programmed death receptor-1 (PD-1) blockade has been reported to improve the prognosis of locally advanced esophageal squamous cell carcinoma (ESCC). This study was aimed to evaluate the efficacy and safety of neoadjuvant camrelizumab plus chemoradiotherapy in locally ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fei, Qiu, Lingdong, Mu, Yushu, Sun, Shibin, Yuan, Yulong, Shang, Pan, Ji, Bo, Wang, Qifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379096/
https://www.ncbi.nlm.nih.gov/pubmed/35983558
http://dx.doi.org/10.3389/fsurg.2022.893372